|
Volumn 7, Issue 6, 2001, Pages 504-510
|
A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation
a b c d e f g h h h |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALBUMIN;
ANTIVIRUS AGENT;
BILIRUBIN;
HEPATITIS B SURFACE ANTIGEN;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
VIRUS DNA;
ADULT;
AGED;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
GRAFT FAILURE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
LIVER TRANSPLANTATION;
LONG TERM CARE;
MALE;
MULTICENTER STUDY;
PATIENT CARE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RECIPIENT;
RECURRENT DISEASE;
REINFECTION;
TIME;
TREATMENT OUTCOME;
VIROLOGY;
VIRUS MUTANT;
|
EID: 0034965224
PISSN: 15276465
EISSN: None
Source Type: Journal
DOI: 10.1053/jlts.2001.24896 Document Type: Article |
Times cited : (69)
|
References (31)
|